The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
The proceeds from the ?IP will be primarily utilized to meet the cash consideration payable to Mylan Inc. (Viatris) for buying out its shareholding in Biocon Biologics Limited
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company
CHOMax integrates cell line development, process development, analytics, and GMP manufacturing under robust quality processes
The agreement responds directly to President Trump’s demands that drugmakers cut costs for US patients
DME is among the most challenging retinal diseases to treat and has long served as a proving ground for therapies that ultimately become first-line standard of care in retinal diseases
The therapy was well tolerated through Week 24, with a safety profile consistent with Alumis’ Phase 2 data
The work will leverage ProBioGen’s CHO.RiGHT expression platform, powered by its proprietary DirectedLuck transposase technology, alongside PsiBot smart automation
SLE remains a life-threatening autoimmune disease, with patients facing an elevated risk of early mortality and long-term organ damage
Subscribe To Our Newsletter & Stay Updated
